- Public Comps
- Venture Life Group
Venture Life Group Valuation Multiples
Discover Venture Life Group's revenue and EBITDA valuation multiples and M&A history, alongside public comparables like FitLife Brands, Chong Kun Dang Holdings, Vita Life Sciences, Promopharm and more.
Venture Life Group Overview
About Venture Life Group
Venture Life Group PLC is an international consumer self-care company. The company focuses on the development and commercialization of healthcare products, including oral care products, food supplements, medical devices, and cosmetics. The company operates in two segments: Venture Life Brands, which includes sales of branded healthcare and cosmetics products, and Customer Brands, which includes sales of products and services under contract development and manufacturing agreements. Its geographical segments include the United Kingdom, Ireland, Germany, Netherlands, France, the Rest of Europe, other countries, and the Rest of the World.
Founded
2005
HQ

Employees
58
Website
Financials (LTM)
EV
$68M
Valuation Multiples
Start free trialVenture Life Group Financials
Venture Life Group reported last 12-month revenue of $50M and EBITDA of $9M.
In the same LTM period, Venture Life Group generated $14M in gross profit, $9M in EBITDA, and $21M in net income.
Revenue (LTM)
Venture Life Group P&L
In the most recent fiscal year, Venture Life Group reported revenue of $36M and EBITDA of $6M.
Venture Life Group is unprofitable as of last fiscal year, with gross margin of 46%, EBITDA margin of 16%, and net margin of (1%).
Financial data powered by Morningstar, Inc.
Venture Life Group Stock Performance
Venture Life Group has current market cap of $113M, and enterprise value of $68M.
Market Cap Evolution
Venture Life Group's stock price is $0.93.
Venture Life Group share price increased by 6.9% in the last 30 days, and by 16.6% in the last year.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $68M | $113M | -0.2% | 6.9% | 20.5% | 16.6% | $-0.00 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialVenture Life Group Valuation Multiples
Venture Life Group trades at 1.4x EV/Revenue multiple, and 7.7x EV/EBITDA.
EV / Revenue (LTM)
Venture Life Group Financial Valuation Multiples
As of July 19, 2026, Venture Life Group has market cap of $113M and EV of $68M.
Venture Life Group has a P/E ratio of 5.5x.
Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Venture Life Group Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.


Venture Life Group Margins & Growth Rates
Venture Life Group grew revenue by 30% and EBITDA by 35% in the last fiscal year.
In the most recent fiscal year, Venture Life Group reported gross margin of 46%, EBITDA margin of 16%, and net margin of (1%).
Venture Life Group Margins
Venture Life Group Growth Rates
Data powered by FactSet, Inc. and Morningstar, Inc.
Venture Life Group Operational KPIs
Venture Life Group's revenue per employee in the last FY averaged $0.6M, while opex per employee averaged $0.2M for the same period.
Venture Life Group's Rule of 40 is 54% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Venture Life Group's Rule of X is 105% (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Data powered by FactSet, Inc. and Morningstar, Inc.
Venture Life Group Competitors
Venture Life Group competitors include FitLife Brands, Chong Kun Dang Holdings, Vita Life Sciences, Promopharm, Hofseth BioCare, Hyundai Bioland Co, Enzymatica, Biome Australia, Provexis and Niagen Bioscience.
Most Venture Life Group public comparables operate across Nutraceuticals & Cosmeceuticals.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| 1.8x | 1.5x | 10.3x | 9.7x | |||
| 0.6x | - | 4.7x | - | |||
| 1.1x | - | 6.7x | - | |||
| 0.9x | - | 7.4x | - | |||
| 3.8x | - | (13.6x) | - | |||
| 0.7x | - | 5.2x | - | |||
| 9.3x | 9.3x | (11.5x) | - | |||
| 3.0x | 2.3x | 87.3x | 18.4x | |||
This data is available for Pro users. Sign up to see all Venture Life Group competitors and their valuation data. Start Free Trial | ||||||
Acquisitions by Venture Life Group
Venture Life Group has acquired 6 companies to date.
Last acquisition by Venture Life Group was on June 1st 2026. Venture Life Group acquired CUROXEN for $28M (EV/Revenue multiple available to Pro users).
Latest Acquisitions by Venture Life Group
| Description | CUROXEN is a maker of first aid ointments. The company offers products including oxygenated olive oil and calendula for pain relief, infection prevention, and healing. | Femiclear is a company that offers over-the-counter women's health products addressing vaginal infections, irritation, odor, and related intimate-care needs. | BBI Healthcare is a Crumlin-based manufacturer developing continence care products including male guards, pads, pull-up pants, and institutional packs. The company produces absorbent solutions under the Select and Tena brands for distribution across the UK and Ireland. Its ISO 13485-certified facility in Northern Ireland focuses on dermatologically tested, odor-control products for moderate to heavy incontinence needs. BBI Healthcare supplies NHS trusts and pharmacies since 1989. | Pharma Source is a Netherlands-based distributor of pharmaceutical raw materials including APIs, solvents, and packaging components sourced from certified suppliers in India and China. Headquartered in Rotterdam since 1998, it supplies excipients like microcrystalline cellulose to Dutch contract manufacturers and adheres to EDQM standards for European markets. | |
| HQ Country | |||||
| HQ City | Austin, TX | Austin, TX | Bridgend | Rotterdam | |
| Deal Date | 1 Jun 2026 | 1 Jun 2026 | 7 Jun 2021 | 19 Dec 2019 | |
| Valuation | $28M | $28M | $46M | $7M | |
| EV/Revenue | |||||
| EV/EBITDA | |||||
This data is available for Pro users. Sign up to see all Venture Life Group acquisitions and their M&A valuation multiples. Start Free Trial | |||||
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Venture Life Group
| When was Venture Life Group founded? | Venture Life Group was founded in 2005. |
| Where is Venture Life Group headquartered? | Venture Life Group is headquartered in United Kingdom. |
| How many employees does Venture Life Group have? | As of today, Venture Life Group has over 58 employees. |
| Who is the CEO of Venture Life Group? | Venture Life Group's CEO is Jeremy Anthony Philip Jerry Randall. |
| Is Venture Life Group publicly listed? | Yes, Venture Life Group is a public company listed on London Stock Exchange. |
| What is the stock symbol of Venture Life Group? | Venture Life Group trades under VLG ticker. |
| When did Venture Life Group go public? | Venture Life Group went public in 2014. |
| Who are competitors of Venture Life Group? | Venture Life Group main competitors include FitLife Brands, Chong Kun Dang Holdings, Vita Life Sciences, Promopharm, Hofseth BioCare, Hyundai Bioland Co, Enzymatica, Biome Australia, Provexis, Niagen Bioscience. |
| What is the current market cap of Venture Life Group? | Venture Life Group's current market cap is $113M. |
| What is the current revenue of Venture Life Group? | Venture Life Group's last 12 months revenue is $50M. |
| What is the current revenue growth of Venture Life Group? | Venture Life Group revenue growth (NTM/LTM) is 49%. |
| What is the current EV/Revenue multiple of Venture Life Group? | Current revenue multiple of Venture Life Group is 1.4x. |
| What is the current EBITDA of Venture Life Group? | Venture Life Group's last 12 months EBITDA is $9M. |
| What is Venture Life Group's EBITDA margin? | Venture Life Group's last 12 months EBITDA margin is 18%. |
| What is the current EV/EBITDA multiple of Venture Life Group? | Current EBITDA multiple of Venture Life Group is 7.7x. |
| What is the current FCF of Venture Life Group? | Venture Life Group's last 12 months FCF is $7M. |
| What is Venture Life Group's FCF margin? | Venture Life Group's last 12 months FCF margin is 13%. |
| What is the current EV/FCF multiple of Venture Life Group? | Current FCF multiple of Venture Life Group is 10.2x. |
| How many companies Venture Life Group has acquired to date? | As of July 2026, Venture Life Group has acquired 6 companies. |
| What was the largest acquisition by Venture Life Group? | $46M acquisition of BBI Healthcare on 7th June 2021 was the largest M&A Venture Life Group has done to date. |
| What companies Venture Life Group acquired? | Venture Life Group acquired BBI Healthcare, CUROXEN, FemiClear, Pharma Source, UltraDEX, and Biokosmes. |
| In how many companies Venture Life Group has invested to date? | Venture Life Group hasn't invested in any companies yet (or none have been disclosed publicly). |
See public comps similar to Venture Life Group
Lists including Venture Life Group
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.







